Yuriko Shimizu

Sagamihara, 2520374, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical Cystectomy.

Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical Cystectomy.

Journal: Cancers

Published: March 11, 2025

Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer.

Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: August 31, 2023

Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy.

Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy.

Journal: International journal of molecular sciences

Published: August 25, 2023

Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy.

Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy.

Journal: International journal of molecular sciences

Published: August 24, 2022

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.

Journal: Cancers

Published: April 13, 2022

Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.

Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.

Journal: Cancers

Published: February 10, 2022

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.

Journal: Cancers

Published: September 04, 2021

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy.

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy.

Journal: Cancers

Published: March 07, 2021

PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.

PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.

Journal: Urologic oncology

Published: August 07, 2020

High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.

High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.

Journal: Urologic oncology

Published: August 04, 2020

Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study.

Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 17, 2020

TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.

TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.

Journal: Cancer biomarkers : section A of Disease markers

Published: November 27, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026